NCT04402073

Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: TERMINATED

Phase: PHASE2

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Condition: Medulloblastoma

Signal summary

Status signal: Registry Stop Signal

Timeline signals: None

Results signal: Low Signal

Operational burden: rare_population_signal

Stopped reason

Poor accrual